Ameer has a back ground in sociology. Prior to joining George Institute he served as Field Manager in the Administrative Staff College of India and Public Health Foundation of India. He has more than ten years experience in planning and managing large scale population based public health research studies.

He has particular expertise in community mobilization, site assessments, field management, and participatory mapping. He is currently working on the SMART Health project.

As a Research Strategy & Services Advisor, Carlyn manages the administration of a range of funding, from the initial process of application through to post-award management.

In her role as Quality Assurance Coordinator, she is involved in the implementation of academic risk management processes.

Carlyn joined The George Institute in 2011. She has a PhD in Infectious Diseases & Immunology and additional Commercialisation training through the Graduate Certificate in Innovation & Enterprise program through The University of Sydney.

Richard Lindley is Professor of Geriatric Medicine at Sydney Medical School (Westmead Hospital Clinical School), University of Sydney. His career has focused on finding reliable new evidence to improve treatments for older people, particularly stroke.

He continues in hospital clinical practice (acute geriatric medicine, rehabilitation and stroke at Blacktown Hospital, Sydney) and runs a large portfolio of clinical trials and projects within different groups at The George Institute.

He is an Associate Editor for the Australasian Journal on Ageing and an Honorary Overseas Member of the British Association of Neurologists. He has published widely on clinical aspects of stroke, vascular disease, vaccination, infectious disease and geriatric medicine.

Stacey Jankelowitz is a staff specialist neurologist and clinical neurophysiologist at Royal Prince Alfred Hospital. Stacey was recently awarded an NHMRC TRIP fellowship. She implemented NHMRC guidelines for secondary prevention of stroke as her TRIP project. She is currently participating in a study to implement changes in care for patients with intracranial haemorrhage.

Her research interests include stroke, implementation science and neurophysiological testing of the central and peripheral nervous system in stroke and motor function.

Paula is a PhD student at The George Institute and the Faculty of Medicine at the University of Sydney. She is visiting from Chile where she worked as a Stroke Neurologist in Clinica Alemana de Santiago - Universidad del Desarrollo, as well as a research coordinator.

John is a Senior Project Officer with the Cardiovascular Division.  He is working on the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study. This study is assessing a multi-faceted, consumer-focussed e-health strategy to assist people to lower their risks of a cardiovascular disease (CVD) event.

Mark Woodward is Chair of Statistics, Epidemiology and Women’s Health at Imperial College London and Professor of Medical Statistics at the University of New South Wales in Sydney. He is also a visiting /honorary professor at the universities of Dundee, Glasgow and the West Indies. He is an Associate Fellow of Green Templeton College, University of Oxford. Mark was Professor of Statistics and Epidemiology at the University of Oxford from September 2013 to July 2020 and has also been a professor at the universities of New York, Sydney and Johns Hopkins (adjunct). 

He is the author of over a thousand scientific articles and two text-books on statistical methods in medical research, one of which has its fourth edition commissioned for 2025. He was named by Thomson Reuters/Clarivate Analytics as one of ‘The World’s Most Influential Scientific Minds’ in each of the last 11 years. As of June 2025, he has a H Factor of 188 with total citations of 164,594; 16 of his papers have over a thousand citations.

Mark has led four major international studies and directed the analytical research on three landmark collaborative studies, worldwide. His work on cardiovascular risk scores formed the basis of national guidelines in Scotland, and his work on kidney disease was used to produce new staging criteria for this disease. His total career grant awards total over £100 million from 64 successful applications.

He also has extensive experience in student teaching, postgraduate supervision and mentoring, including 14 PhD and 20 MSc students successfully completed. He has given training workshops in Botswana, China including Taiwan, Korea, Thailand, Uganda, Vietnam, Zambia and Zimbabwe.

Mark served on the governing council of the Institute of Statisticians and the Royal Statistical Society (RSS) and is a fellow of the RSS, the European Society of Cardiology and the New York Academy of Medicine. He is an Honorary Fellow of the Royal Society of Physicians of Thailand.

He has wide experience of development aid work in Africa and Asia, having undertaken 25 missions for aid agencies, such as the WHO. He has also assessed grants for six national medical research councils (including NHMRC) and served on the editorial boards of seven international journals.
 

Associate Professor Tom Briffa is an allied health practitioner and advocate who has devoted some 25 years to examining trends and models of care in cardiovascular disease treatment and management in Australia. His research targets the prevention and treatment of cardiovascular disease and its translation into practice.

Tom works with a network of dynamic health professionals globally from his base at the University of Western Australia. He was a founding member of state, national and international associations for cardiac rehabilitation and has held a variety of honorary positions with the peak health agencies.

Professor David Brieger is an interventional cardiologist and head of the coronary care and coronary interventions at Concord Hospital and Professor of Cardiology, University of Sydney. His particular clinical interests include coronary disease and atrial fibrillation and he practices across the full spectrum of cardiac disease. He maintains an active research interest in new antithrombotic drugs for cardiac conditions, and the promotion of high quality care for patients during and following their hospitalization.

Professor Derek Chew is a clinical and interventional cardiologist as well as a clinical trialist and outcomes researcher in cardiovascular medicine. He has completed a Masters of Public Health at the Harvard School of Public Health in quantitative methods.

He is a Senior Principal Research Fellow in Cardiovascular Outcomes Research, and is the Regional Head of Cardiology for the Adelaide Health Service (Southern Region). Derek is the Head of the Flinders Clinical Trial Centre, and Chair of the Statewide Cardiology Clinical Network.

His clinical and research career is centred on the translation of current and future therapies and technologies in cardiology to improved patient outcomes in a clinically effective manner.

Dr Andre Pascal Kengne  earned his MD degree from the Faculty of Medicine and Biomedical Sciences, University of Yaounde 1, Cameroon. He did his residency training in internal medicine at the Yaounde University Teaching Hospital. In 2009, he obtained a PhD in Medicine from the University of Sydney, Australia, the major focus of which was cardiovascular epidemiology and prevention.

Dr Kengne is a Fellow of the International Society of Hypertension, The George Institute for Global Health, Australia, The Julius Center for Health Science and Primary Care (Netherlands); member of the American Society of Hypertension, High blood pressure Council of Australia and many other local/regional societies. He is on the editorial board of the Cardiovascular Journal of Africa and Pan-African Medical Journal, and serves as reviewer for several additional medical journals.

He has authored numerous articles and book chapters in the areas of cardiovascular diseases, diabetes and chronic diseases, and clinical decision making, and has lectured in Cameroon and abroad on these topics. He has been involved in many research projects in Cameroon, Europe and in Australia, including the ADVANCE trial and the Asia Pacific Cohort Studies Collaboration.

He joins the MRC South Africa after five consecutive years at the George Institute for Global Health in Sydney, and a brief collaborative visit of six months at the Julius Centre for Health Science and Primary Care in Utrecht.